Trinity Biotech (TRIB) Depreciation & Amortization (CF) (2021 - 2024)
Historic Depreciation & Amortization (CF) for Trinity Biotech (TRIB) over the last 4 years, with Q4 2024 value amounting to $317000.0.
- Trinity Biotech's Depreciation & Amortization (CF) rose 1575000.0% to $317000.0 in Q4 2024 from the same period last year, while for Jun 2025 it was $317195.0, marking a year-over-year increase of 1386104.75%. This contributed to the annual value of $1.2 million for FY2024, which is 2592.59% up from last year.
- Per Trinity Biotech's latest filing, its Depreciation & Amortization (CF) stood at $317000.0 for Q4 2024, which was up 1575000.0% from $260.0 recorded in Q3 2024.
- Over the past 5 years, Trinity Biotech's Depreciation & Amortization (CF) peaked at $478000.0 during Q3 2022, and registered a low of -$65.0 during Q2 2024.
- Moreover, its 4-year median value for Depreciation & Amortization (CF) was $351.0 (2023), whereas its average is $107524.0.
- Over the last 5 years, Trinity Biotech's Depreciation & Amortization (CF) had its largest YoY gain of 1575000.0% in 2024, and its largest YoY loss of 12131.15% in 2024.
- Trinity Biotech's Depreciation & Amortization (CF) (Quarter) stood at $146000.0 in 2021, then surged by 210.27% to $453000.0 in 2022, then tumbled by 99.56% to $2000.0 in 2023, then soared by 15750.0% to $317000.0 in 2024.
- Its Depreciation & Amortization (CF) stands at $317000.0 for Q4 2024, versus $260.0 for Q3 2024 and -$65.0 for Q2 2024.